 | • レポートコード：MRC2-11QY11367 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は慢性肺疾患治療のグローバル市場について調査・分析したレポートです。種類別（注射、カプセル、錠剤、その他）市場規模、用途別（気管支肺異形成症、喘息、COPD、肺線維症）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別慢性肺疾患治療の競争状況、市場シェア ・世界の慢性肺疾患治療市場：種類別市場規模 2015年-2020年（注射、カプセル、錠剤、その他） ・世界の慢性肺疾患治療市場：種類別市場規模予測 2021年-2026年（注射、カプセル、錠剤、その他） ・世界の慢性肺疾患治療市場：用途別市場規模 2015年-2020年（気管支肺異形成症、喘息、COPD、肺線維症） ・世界の慢性肺疾患治療市場：用途別市場規模予測 2021年-2026年（気管支肺異形成症、喘息、COPD、肺線維症） ・北米の慢性肺疾患治療市場分析：米国、カナダ ・ヨーロッパの慢性肺疾患治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの慢性肺疾患治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の慢性肺疾患治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの慢性肺疾患治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Boehringer Ingelheim、Novartis、Roche、Astellas Pharma、Dr. Reddy’s Laboratories、GlaxoSmithKline、AstraZeneca、Sanofi、Teva Pharmaceuticals、Asmacure Ltée ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Lung disease is a very common medical condition that is present in almost every region of the world. Chronic lung diseases can be dangerous and if not treated properly can cause death. The chronic lung diseases cause uneasiness and complications in the respiratory system thus causing difficulty in respiration.
Market Analysis and Insights: Global Chronic Lung Diseases Treatment Market
The global Chronic Lung Diseases Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chronic Lung Diseases Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chronic Lung Diseases Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chronic Lung Diseases Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chronic Lung Diseases Treatment market.
Global Chronic Lung Diseases Treatment Scope and Market Size
Chronic Lung Diseases Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Lung Diseases Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Injection
Capsule
Tablet
Other
Market segment by Application, split into
Bronchopulmonary Dysplasia
Asthma
COPD
Pulmonary Fibrosis
Based on regional and country-level analysis, the Chronic Lung Diseases Treatment market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Chronic Lung Diseases Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Boehringer Ingelheim
Novartis
Roche
Astellas Pharma
Dr. Reddy’s Laboratories
GlaxoSmithKline
AstraZeneca
Sanofi
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Lung Diseases Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Injection
1.2.3 Capsule
1.2.4 Tablet
1.2.5 Other
1.3 Market by Application
1.3.1 Global Chronic Lung Diseases Treatment Market Share by Application: 2020 VS 2026
1.3.2 Bronchopulmonary Dysplasia
1.3.3 Asthma
1.3.4 COPD
1.3.5 Pulmonary Fibrosis
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chronic Lung Diseases Treatment Market Perspective (2015-2026)
2.2 Global Chronic Lung Diseases Treatment Growth Trends by Regions
2.2.1 Chronic Lung Diseases Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Chronic Lung Diseases Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Chronic Lung Diseases Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Lung Diseases Treatment Players by Market Size
3.1.1 Global Top Chronic Lung Diseases Treatment Players by Revenue (2015-2020)
3.1.2 Global Chronic Lung Diseases Treatment Revenue Market Share by Players (2015-2020)
3.2 Global Chronic Lung Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chronic Lung Diseases Treatment Revenue
3.4 Global Chronic Lung Diseases Treatment Market Concentration Ratio
3.4.1 Global Chronic Lung Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Lung Diseases Treatment Revenue in 2019
3.5 Key Players Chronic Lung Diseases Treatment Area Served
3.6 Key Players Chronic Lung Diseases Treatment Product Solution and Service
3.7 Date of Enter into Chronic Lung Diseases Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Lung Diseases Treatment Breakdown Data by Type (2015-2026)
4.1 Global Chronic Lung Diseases Treatment Historic Market Size by Type (2015-2020)
4.2 Global Chronic Lung Diseases Treatment Forecasted Market Size by Type (2021-2026)
5 Chronic Lung Diseases Treatment Breakdown Data by Application (2015-2026)
5.1 Global Chronic Lung Diseases Treatment Historic Market Size by Application (2015-2020)
5.2 Global Chronic Lung Diseases Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Chronic Lung Diseases Treatment Market Size (2015-2026)
6.2 North America Chronic Lung Diseases Treatment Market Size by Type (2015-2020)
6.3 North America Chronic Lung Diseases Treatment Market Size by Application (2015-2020)
6.4 North America Chronic Lung Diseases Treatment Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Chronic Lung Diseases Treatment Market Size (2015-2026)
7.2 Europe Chronic Lung Diseases Treatment Market Size by Type (2015-2020)
7.3 Europe Chronic Lung Diseases Treatment Market Size by Application (2015-2020)
7.4 Europe Chronic Lung Diseases Treatment Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Chronic Lung Diseases Treatment Market Size (2015-2026)
8.2 China Chronic Lung Diseases Treatment Market Size by Type (2015-2020)
8.3 China Chronic Lung Diseases Treatment Market Size by Application (2015-2020)
8.4 China Chronic Lung Diseases Treatment Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Chronic Lung Diseases Treatment Market Size (2015-2026)
9.2 Japan Chronic Lung Diseases Treatment Market Size by Type (2015-2020)
9.3 Japan Chronic Lung Diseases Treatment Market Size by Application (2015-2020)
9.4 Japan Chronic Lung Diseases Treatment Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Chronic Lung Diseases Treatment Market Size (2015-2026)
10.2 Southeast Asia Chronic Lung Diseases Treatment Market Size by Type (2015-2020)
10.3 Southeast Asia Chronic Lung Diseases Treatment Market Size by Application (2015-2020)
10.4 Southeast Asia Chronic Lung Diseases Treatment Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Chronic Lung Diseases Treatment Introduction
11.1.4 Boehringer Ingelheim Revenue in Chronic Lung Diseases Treatment Business (2015-2020))
11.1.5 Boehringer Ingelheim Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Chronic Lung Diseases Treatment Introduction
11.2.4 Novartis Revenue in Chronic Lung Diseases Treatment Business (2015-2020)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Chronic Lung Diseases Treatment Introduction
11.3.4 Roche Revenue in Chronic Lung Diseases Treatment Business (2015-2020)
11.3.5 Roche Recent Development
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Details
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Chronic Lung Diseases Treatment Introduction
11.4.4 Astellas Pharma Revenue in Chronic Lung Diseases Treatment Business (2015-2020)
11.4.5 Astellas Pharma Recent Development
11.5 Dr. Reddy’s Laboratories
11.5.1 Dr. Reddy’s Laboratories Company Details
11.5.2 Dr. Reddy’s Laboratories Business Overview
11.5.3 Dr. Reddy’s Laboratories Chronic Lung Diseases Treatment Introduction
11.5.4 Dr. Reddy’s Laboratories Revenue in Chronic Lung Diseases Treatment Business (2015-2020)
11.5.5 Dr. Reddy’s Laboratories Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Chronic Lung Diseases Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Chronic Lung Diseases Treatment Business (2015-2020)
11.6.5 GlaxoSmithKline Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Chronic Lung Diseases Treatment Introduction
11.7.4 AstraZeneca Revenue in Chronic Lung Diseases Treatment Business (2015-2020)
11.7.5 AstraZeneca Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Chronic Lung Diseases Treatment Introduction
11.8.4 Sanofi Revenue in Chronic Lung Diseases Treatment Business (2015-2020)
11.8.5 Sanofi Recent Development
11.9 Teva Pharmaceuticals
11.9.1 Teva Pharmaceuticals Company Details
11.9.2 Teva Pharmaceuticals Business Overview
11.9.3 Teva Pharmaceuticals Chronic Lung Diseases Treatment Introduction
11.9.4 Teva Pharmaceuticals Revenue in Chronic Lung Diseases Treatment Business (2015-2020)
11.9.5 Teva Pharmaceuticals Recent Development
11.10 Asmacure Ltée
11.10.1 Asmacure Ltée Company Details
11.10.2 Asmacure Ltée Business Overview
11.10.3 Asmacure Ltée Chronic Lung Diseases Treatment Introduction
11.10.4 Asmacure Ltée Revenue in Chronic Lung Diseases Treatment Business (2015-2020)
11.10.5 Asmacure Ltée Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Chronic Lung Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Injection
Table 4. Key Players of Capsule
Table 5. Key Players of Tablet
Table 6. Key Players of Other
Table 7. Global Chronic Lung Diseases Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Chronic Lung Diseases Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Chronic Lung Diseases Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Chronic Lung Diseases Treatment Market Share by Regions (2015-2020)
Table 11. Global Chronic Lung Diseases Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Chronic Lung Diseases Treatment Market Share by Regions (2021-2026)
Table 13. Chronic Lung Diseases Treatment Market Market Trends
Table 14. Chronic Lung Diseases Treatment Market Drivers
Table 15. Chronic Lung Diseases Treatment Market Challenges
Table 16. Chronic Lung Diseases Treatment Market Restraints
Table 17. Global Chronic Lung Diseases Treatment Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Chronic Lung Diseases Treatment Market Share by Players (2015-2020)
Table 19. Global Top Chronic Lung Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Lung Diseases Treatment as of 2019)
Table 20. Global Chronic Lung Diseases Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Chronic Lung Diseases Treatment Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Chronic Lung Diseases Treatment Market Size by Type (2015-2020) (US$ Million)
Table 25. Global Chronic Lung Diseases Treatment Market Size Share by Type (2015-2020)
Table 26. Global Chronic Lung Diseases Treatment Revenue Market Share by Type (2021-2026)
Table 27. Global Chronic Lung Diseases Treatment Market Size Share by Application (2015-2020)
Table 28. Global Chronic Lung Diseases Treatment Market Size by Application (2015-2020) (US$ Million)
Table 29. Global Chronic Lung Diseases Treatment Market Size Share by Application (2021-2026)
Table 30. North America Chronic Lung Diseases Treatment Market Size by Type (2015-2020) (US$ Million)
Table 31. North America Chronic Lung Diseases Treatment Market Share by Type (2015-2020)
Table 32. North America Chronic Lung Diseases Treatment Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Chronic Lung Diseases Treatment Market Share by Application (2015-2020)
Table 34. North America Chronic Lung Diseases Treatment Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Chronic Lung Diseases Treatment Market Share by Country (2015-2020)
Table 36. Europe Chronic Lung Diseases Treatment Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe Chronic Lung Diseases Treatment Market Share by Type (2015-2020)
Table 38. Europe Chronic Lung Diseases Treatment Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe Chronic Lung Diseases Treatment Market Share by Application (2015-2020)
Table 40. Europe Chronic Lung Diseases Treatment Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Chronic Lung Diseases Treatment Market Share by Country (2015-2020)
Table 42. China Chronic Lung Diseases Treatment Market Size by Type (2015-2020) (US$ Million)
Table 43. China Chronic Lung Diseases Treatment Market Share by Type (2015-2020)
Table 44. China Chronic Lung Diseases Treatment Market Size by Application (2015-2020) (US$ Million)
Table 45. China Chronic Lung Diseases Treatment Market Share by Application (2015-2020)
Table 46. China Chronic Lung Diseases Treatment Market Size by Region (US$ Million) (2015-2020)
Table 47. China Chronic Lung Diseases Treatment Market Share by Region (2015-2020)
Table 48. Japan Chronic Lung Diseases Treatment Market Size by Type (2015-2020) (US$ Million)
Table 49. Japan Chronic Lung Diseases Treatment Market Share by Type (2015-2020)
Table 50. Japan Chronic Lung Diseases Treatment Market Size by Application (2015-2020) (US$ Million)
Table 51. Japan Chronic Lung Diseases Treatment Market Share by Application (2015-2020)
Table 52. Japan Chronic Lung Diseases Treatment Market Size by Country (US$ Million) (2015-2020)
Table 53. Japan Chronic Lung Diseases Treatment Market Share by Country (2015-2020)
Table 54. Southeast Asia Chronic Lung Diseases Treatment Market Size by Type (2015-2020) (US$ Million)
Table 55. Southeast Asia Chronic Lung Diseases Treatment Market Share by Type (2015-2020)
Table 56. Southeast Asia Chronic Lung Diseases Treatment Market Size by Application (2015-2020) (US$ Million)
Table 57. Southeast Asia Chronic Lung Diseases Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Chronic Lung Diseases Treatment Market Size by Country (US$ Million) (2015-2020)
Table 59. Southeast Asia Chronic Lung Diseases Treatment Market Share by Country (2015-2020)
Table 60. Boehringer Ingelheim Company Details
Table 61. Boehringer Ingelheim Business Overview
Table 62. Boehringer Ingelheim Product
Table 63. Boehringer Ingelheim Revenue in Chronic Lung Diseases Treatment Business (2015-2020) (US$ Million)
Table 64. Boehringer Ingelheim Recent Development
Table 65. Novartis Company Details
Table 66. Novartis Business Overview
Table 67. Novartis Product
Table 68. Novartis Revenue in Chronic Lung Diseases Treatment Business (2015-2020) (US$ Million)
Table 69. Novartis Recent Development
Table 70. Roche Company Details
Table 71. Roche Business Overview
Table 72. Roche Product
Table 73. Roche Revenue in Chronic Lung Diseases Treatment Business (2015-2020) (US$ Million)
Table 74. Roche Recent Development
Table 75. Astellas Pharma Company Details
Table 76. Astellas Pharma Business Overview
Table 77. Astellas Pharma Product
Table 78. Astellas Pharma Revenue in Chronic Lung Diseases Treatment Business (2015-2020) (US$ Million)
Table 79. Astellas Pharma Recent Development
Table 80. Dr. Reddy’s Laboratories Company Details
Table 81. Dr. Reddy’s Laboratories Business Overview
Table 82. Dr. Reddy’s Laboratories Product
Table 83. Dr. Reddy’s Laboratories Revenue in Chronic Lung Diseases Treatment Business (2015-2020) (US$ Million)
Table 84. Dr. Reddy’s Laboratories Recent Development
Table 85. GlaxoSmithKline Company Details
Table 86. GlaxoSmithKline Business Overview
Table 87. GlaxoSmithKline Product
Table 88. GlaxoSmithKline Revenue in Chronic Lung Diseases Treatment Business (2015-2020) (US$ Million)
Table 89. GlaxoSmithKline Recent Development
Table 90. AstraZeneca Company Details
Table 91. AstraZeneca Business Overview
Table 92. AstraZeneca Product
Table 93. AstraZeneca Revenue in Chronic Lung Diseases Treatment Business (2015-2020) (US$ Million)
Table 94. AstraZeneca Recent Development
Table 95. Sanofi Business Overview
Table 96. Sanofi Product
Table 97. Sanofi Company Details
Table 98. Sanofi Revenue in Chronic Lung Diseases Treatment Business (2015-2020) (US$ Million)
Table 99. Sanofi Recent Development
Table 100. Teva Pharmaceuticals Company Details
Table 101. Teva Pharmaceuticals Business Overview
Table 102. Teva Pharmaceuticals Product
Table 103. Teva Pharmaceuticals Revenue in Chronic Lung Diseases Treatment Business (2015-2020) (US$ Million)
Table 104. Teva Pharmaceuticals Recent Development
Table 105. Asmacure Ltée Company Details
Table 106. Asmacure Ltée Business Overview
Table 107. Asmacure Ltée Product
Table 108. Asmacure Ltée Revenue in Chronic Lung Diseases Treatment Business (2015-2020) (US$ Million)
Table 109. Asmacure Ltée Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Lung Diseases Treatment Market Share by Type: 2020 VS 2026
Figure 2. Injection Features
Figure 3. Capsule Features
Figure 4. Tablet Features
Figure 5. Other Features
Figure 6. Global Chronic Lung Diseases Treatment Market Share by Application: 2020 VS 2026
Figure 7. Bronchopulmonary Dysplasia Case Studies
Figure 8. Asthma Case Studies
Figure 9. COPD Case Studies
Figure 10. Pulmonary Fibrosis Case Studies
Figure 11. Chronic Lung Diseases Treatment Report Years Considered
Figure 12. Global Chronic Lung Diseases Treatment Market Size (US$ Million), YoY Growth 2015-2026
Figure 13. Global Chronic Lung Diseases Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Chronic Lung Diseases Treatment Market Share by Regions (2021-2026)
Figure 15. Global Chronic Lung Diseases Treatment Market Share by Players in 2019
Figure 16. Global Top Chronic Lung Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Lung Diseases Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Chronic Lung Diseases Treatment Revenue in 2019
Figure 18. North America Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. United States Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Europe Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Rest of Europe Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Asia-Pacific Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. China Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Japan Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. South Korea Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Southeast Asia Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. India Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Australia Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Rest of Asia-Pacific Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Latin America Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Mexico Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Brazil Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Middle East & Africa Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Turkey Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Saudi Arabia Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. UAE Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Rest of Middle East & Africa Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Boehringer Ingelheim Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2015-2020)
Figure 46. Novartis Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2015-2020)
Figure 47. Roche Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2015-2020)
Figure 48. Astellas Pharma Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2015-2020)
Figure 49. Dr. Reddy’s Laboratories Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2015-2020)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2015-2020)
Figure 51. AstraZeneca Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2015-2020)
Figure 52. Sanofi Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2015-2020)
Figure 53. Teva Pharmaceuticals Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2015-2020)
Figure 54. Asmacure Ltée Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2015-2020)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
希少性肺疾患治療の世界市場（～2026年） Orphan illnesses are those which are not generally looked into, those where particular medicines are not accessible, and those which may just be of restricted enthusiasm to researchers and specialists. Orphan lung diseases are exemplified by the purported disregarded infectious diseases, which are e…- 慢性疾患管理の世界市場（～2026年） Chronic Disease Management which was also known as enhanced primary care earlier is the ongoing care and support which help in managing the health care of patient suffering with chronic disease such as asthma, cancer, diabetes, cardiovascular diseases, stroke, etc. It also require visits and support…
- 慢性肝疾患治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chronic Liver Diseases Therapeutics Market The global Chronic Liver Diseases Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and hig…
- 慢性閉塞性肺疾患治療の世界市場（～2026年） Market Analysis and Insights: Global Chronic Obstructive Pulmonary Disease Treatment Market The global Chronic Obstructive Pulmonary Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chronic Obstructive…
- 慢性閉塞性肺疾患（COPD）の世界市場（～2026年） Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eve…